Hepatic energy state is regulated by glucagon receptor signaling in mice

Journal of Clinical Investigation

Volumn 119, Issue 8, 2009, Pages 2412-2422

  Berglund, Eric D ^a,c   Lee Young, Robert S ^a   Lustig, Daniel G ^a   Lynes, Sara E ^a   Donahue, E Patrick ^a   Camacho, Raul C ^a   Meredith, M Elizabeth ^a   Magnuson, Mark A ^a   Charron, Maureen J ^b   Wasserman, David H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCAGON; GLUCAGON RECEPTOR; INSULIN; PHLORIZIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIET RESTRICTION; ENERGY METABOLISM; ENZYME ACTIVITY; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RESPONSE; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; LIPID DIET; LIVER; LIVER METABOLISM; METABOLIC STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TISSUE SPECIFICITY; TREADMILL EXERCISE;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ENERGY METABOLISM; GLUCAGON; LIVER; MALE; MICE; MICE, INBRED C57BL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 68849090270     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38650     Document Type: Article

References (77)

1. Hardie, D.G., and Hawley, S.A. 2001. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays. 23:1112-1119.
2. Cheung, P.C., Salt, I.P., Davies, S.P., Hardie, D.G., and Carling, D. 2000. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346:659-669.
3. Cohen, P.F., and Colman, R.F. 1972. Diphosphopyridine nucleotide dependent isocitrate dehydrogenase from pig heart. Charactgerization of the active substrate and modes of regulation. Biochemistry. 11:1501-1508.
4. Ercan, N., Gannon, M.C., and Nuttall, F.Q. 1996. Allosteric regulation of liver phosphorylase a: revisited under approximated physiological conditions. Arch. Biochem. Biophys. 328:255-264.
5. Ercan-Fang, N., et al. 2002. Integrated effects of multiple modulators on human liver glycogen phosphorylase a. Am. J. Physiol. Endocrinol. Metab. 283:E29-E37.
6. Nelson, S.W., Honzatko, R.B., and Fromm, H.J. 2002. Hybrid tetramers of porcine liver fructose-1,6-bisphosphatase reveal multiple pathways of allosteric inhibition. J. Biol. Chem. 277:15539-15545.
7. Hardie, D.G., Salt, I.P., Hawley, S.A., and Davies, S.P. 1999. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338:717-722.
8. Atkinson, D.E. 1977. Cellular energy metabolism and its regulation. Academic Press. New York, New York, USA. 304 pp.
9. Ramaiah, A., Hathaway, J.A., and Atkinson, D.E. 1964. Adenylate as a metabolic regulator. Effect on yeast phosphofructokinase kinetics. J. Biol. Chem. 239:3619-3622.
10. Hardie, D.G., Hawley, S.A., and Scott, J.W. 2006. AMP-activated protein kinase - development of the energy sensor concept. J. Physiol. 574:7-15.
11. Camacho, R.C., et al. 2006. Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice. Am. J. Physiol. Endocrinol. Metab. 290:E405-E408.
12. Ponticos, M., et al. 1998. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17:1688-1699.
13. Sauer, U., and Schlattner, U. 2004. Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state. Metab. Eng. 6:220-228.
14. Camacho, R.C., Lacy, D.B., James, F.D., Donahue, E.P., and Wasserman, D.H. 2005. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin. Am. J. Physiol. Endocrinol. Metab. 289:E1039-E1043.
15. Camacho, R.C., et al. 2005. Portal venous 5-aminoimidazole-4-carboxamide- 1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output. Diabetes. 54:373-382.
16. Pencek, R.R., et al. 2005. 5-Aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside causes acute hepatic insulin resistance in vivo. Diabetes. 54:355-360.
17. Alford, F.P., Zimmet, P., Chisholm, D.J., and Whitehouse, S. 1983. Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans. Clin. Endocrinol. (Oxf.). 19:721-725.
18. Fueger, P.T., et al. 2007. Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. J. Physiol. 582:801-812.
19. Galbo, H., Holst, J.J., and Christensen, N.J. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38:70-76.
20. Gerich, J.E., et al. 1974. Characterization of the glucagon response to hypoglycemia in man. J. Clin. Endocrinol. Metab. 38:77-82.
21. Marliss, E.B., Aoki, T.T., Unger, R.H., Soeldner, J.S., and Cahill, G.F., Jr. 1970. Glucagon levels and metabolic effects in fasting man. J. Clin. Invest. 49:2256-2270.
22. Seitz, H.J., Muller, M.J., Krone, W., and Tarnowski, W. 1977. Coordinate control of intermediary metabolism in rat liver by the insulin/glucagon ratio during starvation and after glucose refeeding. Regulatory significance of long-chain acyl-CoA and cyclic AMP. Arch. Biochem. Biophys. 183:647-663.
23. Starke, A.A., Erhardt, G., Berger, M., and Zimmermann, H. 1984. Elevated pancreatic glucagon in obesity. Diabetes. 33:277-280.
24. Unger, R.H., and Orci, L. 1976. Physiology and pathophysiology of glucagon. Physiol. Rev. 56:778-826.
25. Kimball, S.R., Siegfried, B.A., and Jefferson, L.S. 2004. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J. Biol. Chem. 279:54103-54109.
26. Longuet, C., et al. 2008. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab. 8:359-371.
27. Krishna, M.G., et al. 2000. Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal. Am. J. Physiol. Endocrinol. Metab. 279:E638-E645.
28. Wasserman, D.H., Lacy, D.B., Goldstein, R.E., Williams, P.E., and Cherrington, A.D. 1989. Exerciseinduced fall in insulin and increase in fat metabolism during prolonged muscular work. Diabetes. 38:484-490.
29. Wasserman, D.H., et al. 1989. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am. J. Physiol. 257:E108-E117.
30. Berglund, E.D., et al. 2008. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes. 57:1790-1799.
31. Gelling, R.W., et al. 2003. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 100:1438-1443.
32. Hawley, S.A., et al. 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2:28.
33. Carlson, C.L., and Winder, W.W. 1999. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise. J. Appl. Physiol. 86:669-674.
34. Witters, L.A., and Kemp, B.E. 1992. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase. J. Biol. Chem. 267:2864-2867.
35. Munday, M.R., Milic, M.R., Takhar, S., Holness, M.J., and Sugden, M.C. 1991. The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat. Biochem. J. 280:733-737.
36. Bravo, C., et al. 2001. Metabolic changes induced by cold stress in rat liver mitochondria. J. Bioenerg. Biomembr. 33:289-301.
37. Dohm, G.L., and Newsholme, E.A. 1983. Metabolic control of hepatic gluconeogenesis during exercise. Biochem. J. 212:633-639.
38. Ghanbari-Niaki, A., Bergeron, R., Latour, M.G., and Lavoie, J.M. 1999. Effects of physical exercise on liver ATP levels in fasted and phosphate-injected rats. Arch. Physiol. Biochem. 107:393-402.
39. Ghanbari-Niaki, A., Desy, F., and Lavoie, J.M. 1999. Effects of phosphate injection on metabolic and hormonal responses to exercise in fructose-injected rats. Physiol. Behav. 67:747-752.
40. Houghton, C.R., Hawkins, R.A., Williamson, D.H., and Krebs, H.A. 1971. The effects of physical training on the metabolic response to short-term severe exercise in the rat. Biochem. J. 124:57P.
41. Mikami, T., and Kitagawa, J. 2006. Intense exercise induces the degradation of adenine nucleotide and purine nucleotide synthesis via de novo pathway in the rat liver. Eur. J. Appl. Physiol. 96:543-550.
42. Start, C., and Newsholme, E.A. 1968. The effects of starvation and alloxan-diabetes on the contents of citrate and other metabolic intermediates in rat liver. Biochem. J. 107:411-415.
43. Williamson, D.H., Veloso, D., Ellington, E.V., and Krebs, H.A. 1969. Changes in the concentrations of hepatic metabolites on administration of dihydroxyacetone or glycerol to starved rats and their relationship to the control of ketogenesis. Biochem. J. 114:575-584.
44. Burgess, S.C., et al. 2006. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice. J. Biol. Chem. 281:19000-19008.
45. Gomez-Valades, A.G., et al. 2008. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes. 57:2199-2210.
46. Klein, D.K., et al. 2007. Lack of AMPKalpha2 enhances pyruvate dehydrogenase activity during exercise. Am. J. Physiol. Endocrinol. Metab. 293:E1242-E1249.
47. Winder, W.W., and Hardie, D.G. 1996. Inactivation of acetyl-CoA carboxylase and activation of AMPactivated protein kinase in muscle during exercise. Am. J. Physiol. 270:E299-E304.
48. Faupel, R.P., Seitz, H.J., Tarnowski, W., Thiemann, V., and Weiss, C. 1972. The problem of tissue sampling from experimental animals with respect to freezing technique, anoxia, stress and narcosis. A new method for sampling rat liver tissue and the physiological values of glycolytic intermediates and related compounds. Arch. Biochem. Biophys. 148:509-522.
49. Jiang, G., and Zhang, B.B. 2003. Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 284:E671-E678.
50. Richter, E.A., and Ruderman, N.B. 2009. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J. 418:261-275.
51. Gauthier, M.S., et al. 2008. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 283:16514-16524.
52. Koh, H.J., et al. 2007. Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem. J. 403:473-481.
53. Burgess, S.C., et al. 2004. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J. Biol. Chem. 279:48941-48949.
54. Burgess, S.C., et al. 2007. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 5:313-320.
55. She, P., et al. 2000. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol. Cell. Biol. 20:6508-6517.
56. Sakamoto, K., Goransson, O., Hardie, D.G., and Alessi, D.R. 2004. Activity of LKB1 and AMPKrelated kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am. J. Physiol. Endocrinol. Metab. 287:E310-E317.
57. Woods, A., et al. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13:2004-2008.
58. Davies, S.P., Helps, N.R., Cohen, P.T., and Hardie, D.G. 1995. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMPactivated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 377:421-425.
59. Sanders, M.J., Grondin, P.O., Hegarty, B.D., Snowden, M.A., and Carling, D. 2007. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403:139-148.
60. Suter, M., et al. 2006. Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281:32207-32216.
61. McGee, S.L., and Hargreaves, M. 2008. AMPK and transcriptional regulation. Front. Biosci. 13:3022-3033.
62. Feige, J.N., et al. 2008. Specific SIRT1 activation mimics low energy levels and protects against dietinduced metabolic disorders by enhancing fat oxidation. Cell Metab. 8:347-358.
63. Canto, C., et al. 2009. AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity. Nature. 458:1056-1060.
64. McGuinness, O.P., Burgin, K., Moran, C., Bracy, D., and Cherrington, A.D. 1994. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am. J. Physiol. 266:E438-E447.
65. Stevenson, R.W., et al. 1987. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes. 36:382-389.
66. Gurd, B.J., Yoshida, Y., Lally, J., Holloway, G.P., and Bonen, A. 2009. The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J. Physiol. 587:1817-1828.
67. Nair, S., Chacko, V.P., Arnold, C., and Diehl, A.M. 2003. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am. J. Gastroenterol. 98:466-470.
68. Solga, S.F., et al. 2008. Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. Liver Int. 28:675-681.
69. Lowell, B.B., and Shulman, G.I. 2005. Mitochondrial dysfunction and type 2 diabetes. Science. 307:384-387.
70. Mantena, S.K., et al. 2009. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem. J. 417:183-193.
71. Garcia-Villafranca, J., Guillen, A., and Castro, J. 2008. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie. 90:460-466.
72. Sriwijitkamol, A., et al. 2007. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and doseresponse study. Diabetes. 56:836-848.
73. Zhou, G., et al. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108:1167-1174.
74. Ayala, J.E., Bracy, D.P., McGuinness, O.P., and Wasserman, D.H. 2006. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 55:390-397.
75. Chan, T.M., and Exton, J.H. 1976. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal. Biochem. 71:96-105.
76. Morgan, C.R., and Lazarow, A. 1962. Immunoassay of insulin using a two-antibody system. Proc. Soc. Exp. Biol. Med. 110:29-32.
77. Macdonald, I.A., and Lake, D.M. 1985. An improved technique for extracting catecholamines from body fluids. J. Neurosci. Methods. 13:239-248.